“Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life” (2024) Bleeding, Thrombosis and Vascular Biology, 3(1). doi:10.4081/btvb.2024.104.